PubRank

Kathryn A Phillips

Author PubWeight™ 53.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000. Ann Intern Med 2005 3.55
2 Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med 2011 3.52
3 Effect of managed care insurance on the use of preventive care for specific ethnic groups in the United States. Med Care 2002 2.34
4 Variation in access to health care for different racial/ethnic groups by the racial/ethnic composition of an individual's county of residence. Med Care 2004 2.25
5 Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health 2007 1.86
6 Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes 2014 1.65
7 The association of race, socioeconomic status, and health insurance status with the prevalence of overweight among children and adolescents. Am J Public Health 2003 1.53
8 Rates and predictors of colorectal cancer screening. Prev Chronic Dis 2006 1.31
9 The effect of area HMO market share on cancer screening. Health Serv Res 2004 1.29
10 How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey. Health Econ 2009 1.27
11 How the new medicare drug benefit could affect vulnerable populations. Health Aff (Millwood) 2006 1.21
12 How does cost matter in health-care discrete-choice experiments? Health Econ 2011 1.15
13 An experiment on simplifying conjoint analysis designs for measuring preferences. Health Econ 2003 1.14
14 Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay. J Oncol Pract 2010 1.14
15 Health technology assessment and private payers' coverage of personalized medicine. J Oncol Pract 2011 1.10
16 Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling. Genet Med 2011 1.07
17 Women's out-of-pocket expenditures and dispensing patterns for oral contraceptive pills between 1996 and 2006. Contraception 2010 1.06
18 Moving beyond the typologies of managed care: the example of health plan predictors of screening mammography. Health Serv Res 2004 1.03
19 A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics 2009 1.01
20 Does patient cost sharing matter? Its impact on recommended versus controversial cancer screening services. Am J Manag Care 2004 0.97
21 Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer. J Natl Compr Canc Netw 2011 0.95
22 Biotechnology and Medicare's new technology policy: lessons from three case studies. Health Aff (Millwood) 2006 0.94
23 Association of regional variation in primary care physicians' colorectal cancer screening recommendations with individual use of colorectal cancer screening. Prev Chronic Dis 2007 0.92
24 Patient costs for medication abortion: results from a study of five clinical practices. Womens Health Issues 2006 0.91
25 Is the prevalence of gatekeeping in a community associated with individual trust in medical care? Med Care 2003 0.90
26 Tradeoffs of using administrative claims and medical records to identify the use of personalized medicine for patients with breast cancer. Med Care 2011 0.90
27 Variation in screening mammography and Papanicolaou smear by primary care physician specialty and gatekeeper plan (United States). Cancer Causes Control 2004 0.88
28 Drug withdrawals in the United States: a systematic review of the evidence and analysis of trends. Curr Drug Saf 2007 0.88
29 Medicare formulary coverage for top-selling biologics. Nat Biotechnol 2009 0.87
30 Looking back at 10 years of trastuzumab therapy: what is the role of HER2 testing? A systematic review of health economic analyses. Per Med 2009 0.87
31 Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome. J Oncol Pract 2012 0.87
32 Colorectal cancer screening differential costs for younger versus older Americans. Am J Prev Med 2006 0.86
33 Capacity building for assessing new technologies: approaches to examining personalized medicine in practice. Per Med 2010 0.85
34 Economic evaluation of targeted cancer interventions: critical review and recommendations. Genet Med 2011 0.85
35 Provider practice models for and costs of delivering medication abortion -- evidence from 11 US abortion care settings. Contraception 2006 0.83
36 Angiotensin receptor blockers on the formularies of Medicare drug plans. J Gen Intern Med 2007 0.83
37 Health technology assessment and private payers's coverage of personalized medicine. Am J Manag Care 2011 0.83
38 Genomic testing and therapies for breast cancer in clinical practice. J Oncol Pract 2011 0.81
39 Genomic testing and therapies for breast cancer in clinical practice. Am J Manag Care 2011 0.81
40 Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care. Breast Cancer Res Treat 2011 0.80
41 Viagra and contraceptives. Health Aff (Millwood) 2003 0.79
42 User characteristics and out-of-pocket expenditures for progestin-only versus combined oral contraceptives. Contraception 2012 0.79
43 Private Companies Providing Health Care Price Data: Who Are They and What Information do They Provide? J Manag Care Med 2014 0.79
44 Effects of simplifying choice tasks on estimates of taste heterogeneity in stated-choice surveys. Soc Sci Med 2009 0.78
45 Influence of patient preferences on the cost-effectiveness of screening for Lynch syndrome. Am J Manag Care 2012 0.78
46 Measuring managed care and its environment using national surveys: a review and assessment. Med Care Res Rev 2006 0.77
47 Evaluating the potential impact of pharmacogenomics on ADRs. J Manag Care Pharm 2003 0.75
48 Willingness to recommend a health plan: who is dissatisfied and what don't they like? Am J Manag Care 2004 0.75
49 Insured women and payment for elective abortion. Womens Health Issues 2008 0.75
50 A qualitative study of insurers' coverage for mifepristone-induced abortion. Manag Care Interface 2005 0.75